This Week in HIV Research: Increased Muscle Area After Starting Treatment Likely Due to Fat Accumulation
This week, a study finds that increased muscle area after starting HIV treatment may be due to fat accumulation within the muscle rather than new muscle formation.
This week, a study finds that abstinence-only programs continue to be ineffective at keeping young people from having sex, and censor valuable information on HIV prevention.
This week, a study finds that the average time it takes to for newly diagnosed patients to enter care is three months.
We look at peroxisomes and neurocognitive impairment; injectable cabotegravir for PrEP; genital bacteria and HIV risk; and how HIV diagnosis relates to intimate partner violence among pregnant women.
This week, a study review finds that early interventions in monkeys, such as broadly neutralizing antibodies, can help lead to viral suppression without treatment.
This week, a study finds that injectable cabotegravir, an investigational integrase inhibitor, is well tolerated and shows promise as pre-exposure prophylaxis (PrEP).
This Week in HIV Research: Effect of Viral Load Perception on Sex, and HIV Prevention Options Needed in U.S. Prisons
This week, a study finds that viral load perception may change sexual behaviors among HIV-positive men who have sex with men.
This week, a study finds a new key step in how HIV binds to CD4 cells, which could lead to the development of new HIV drugs.
This Week in HIV Research: Early Treatment With Broadly Neutralizing Antibodies Suppresses SHIV in Monkeys
This week, a study finds that administering two broadly neutralizing antibodies very early on during infection helped monkeys achieve long-term viral suppression of simian HIV (SHIV).
This Week in HIV Research: Long-Term Nonprogressors Have Greater Thymic Function; and HCV Reinfection Rates Examined
This week, a study finds that thymic function, which is associated with higher CD4 counts in people with HIV, is greater in long-term nonprogressors.